The Corilab Thrombophilia Check-up comprises three genetic testing panels covering 4, 5 and 15 selected variants. These panels are intended to investigate variants that may be considered as part of an assessment of inherited predisposition to thrombosis. The choice of panel should be based on the individual’s personal and family history and discussed with their doctor or specialist.

Thrombophilia is an increased tendency to develop blood clots. It may be inherited or acquired and can involve a range of clinical, genetic and environmental factors.

Genetic testing represents only one part of an overall risk assessment. The presence of a variant does not mean that a blood clot will necessarily develop, while a negative result does not rule out thrombotic risk. Results should therefore be interpreted by a doctor or specialist.